October 7, 2022 -- The world market for interventional x-ray and mobile C-arm equipment is forecast to reach over $4.9 billion by 2026, according to a new report from Signify Research. The world markets for interventional x-ray systems and mobile C-arms increased by 10.2% and 15.5%, respectively, in 2021. The markets recovered strongly as the negative impact of the coronavirus pandemic subsided, and delayed orders were fulfilled.

In the mobile C-arm market, flat-panel detector (FPD) 2D mobile C-arms are forecast to have the fastest growth through to 2026, with a growth in revenue at a compound annual growth rate (CAGR) of 6.5%.

Demand for image intensifier systems is being maintained by emerging regions or low-risk applications such as pain management in developed countries. The U.S., China, Japan, and Western Europe will continue to lead adoption of 3D C-arm technology.

However, the penetration of 3D mobile C-arms must overcome barriers in the U.S. market, such as strong preferences for hybrid operating rooms and Medtronic's O-arm for spinal surgery due to favorable reimbursement.

Within the interventional x-ray market, strong growth is projected for the structural heart market, with left atrial appendage closure procedures and mitral valve interventions maintaining clinical demand.

Interventional neurology is a key growth area within interventional radiology. The increasing number of stroke centers globally, as well as adoption of biplane systems for multidisciplinary use, for instance for vascular procedures, is driving demand for interventional neurology systems. The primary applications for hybrid operating rooms include cardiac and vascular procedures, followed by spinal procedures.

Europe, Middle East, Africa (EMEA)

In the coming years, market growth for both interventional and surgical x-ray equipment is forecast to be positive following a year of market retraction in 2020. Beyond the pandemic, the main growth drivers will continue to be the growing burden of chronic diseases owing to changing lifestyles and the rising need for cost-effective, minimally invasive interventional procedures.

The rising prevalence of chronic conditions, such as cancer, heart disease, and others, and advances in minimally invasive, targeted treatments using imaging guidance continue to drive the market. Increasing competition from Asian manufacturers is increasing the affordability and adoption of image-guided therapy systems in emerging countries.

The increased demand for complex neurology, oncology, and cardiovascular procedures means that hospitals are increasingly prioritizing advanced multidisciplinary equipment. Advanced features such as artificial intelligence (AI), radiation dose management, and treatment-planning capabilities will increase the uptake of more high-end technology in developed countries.

Within the mobile C-arm market, positive growth from 2021 onwards is attributed to the rising geriatric population with a high susceptibility to chronic conditions such as cardiovascular, orthopedic, and respiratory diseases. This, alongside increasing patient awareness of the benefits of minimally invasive procedures, is expected to drive market growth over the forecast period.

Bhvita Jani is a senior marketing analyst at Signify Research. This information was derived from Signify Research's Interventional & Surgical X-ray Equipment - World - 2022, published July 2022. For more information visit Signify's website.

The comments and observations expressed are those of the author and do not necessarily reflect the opinions of AuntMinnie.com.